EUCTR2016-003654-33-DE进行中（未招募）1 期
Effects of the probiotic Saccharomyces boulardii CNCM I-745 and the antibiotic Amoxicillin on the gut microbiota of healthy volunteers An open-label, randomized, parallel groups, monocentric study - Effects of Saccharomyces b. and Amoxicillin on the gut microbiota
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- BIOCODEX
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Subjects enrolled in the study will have to fulfill the following criteria:
- •1)Healthy volunteers aging from 18 to 65 years (male or female)
- •2)Physically and mentally healthy subjects as confirmed by an interview, medical history, clinical examination, laboratory tests and electrocardiogram (ECG)
- •3)With a body mass index (BMI) comprised between 18.5 and 30.0 kg/m2 and weight >50 kg at Screening
- •4)Able to comply with study requirements and to provide signed informed consent
- •5)No clinically relevant abnormalities in results of laboratory tests as per Investigator’s judgement
- •6)For women of childbearing potential
- •oA negative urine pregnancy test immediately prior to starting the study treatment
- •oAgreement to comply with approved methods of contraception during the whole study): unless they meet the criteria of post-menopausal, i.e. 12 months of spontaneous amenorrhea, women of child-bearing potential, defined as all women physiologically capable of becoming pregnant, including women whose career, lifestyle, or sexual orientation precludes intercourse with a male partner, should use one or more of the following acceptable methods of contraception that should be maintained throughout the study:
- •~Surgical sterilization
- •~Hormonal contraception (implantable, patch, oral, intra-muscular)
- •~Intra-uterine device
- •~Double barrier method (diaphragm plus condom)
- •~At the discretion of the investigator, total abstinence is acceptable in cases where age, career, lifestyle, or sexual orientation of the patient ensures compliance
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 48
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Subjects presenting with one of the following criteria will not be enrolled in this study:
- •1)History of hypersensitivity to Saccharomyces boulardii, brewer’s or baker’s yeast, amoxicillin or any other penicillin
- •2)History of a severe immediate hypersensitivity reaction (e.g. anaphylaxis) to another beta-lactam agent (e.g. a cephalosporin, carbapenem or monobactam)
- •3)Hypersensitivity to the active substance, to one of the ingredients, to any of the penicillins or to any of the excipients of the study drugs
- •4)Contraindication and special warning to the study drugs according to the SmPCs
- •5)History of chronic constipation with passage of fewer than 3 spontaneous bowel movements per week on average
- •6)History of chronic or recurrent diarrhea with spontaneous unformed bowel movements equivalent to or more often than 3 times daily
- •7)Prior gastrointestinal surgery (apart from appendectomy or cholecystectomy performed at least more than one year ago)
- •8)History of Clostridium difficile infection
- •9)Known chronic or recurrent systemic disorder that may interfere with the study drug evaluation
- •10)Associated immune deficiency
- •11)Severe hepatic or renal impairment
- •12)Active gastrointestinal disease
- •13)Patients with a central venous catheter
- •14)Oral or systemic antibacterial therapy during the 3 months prior to study enrollment
- •15)New prescription medications during the 2 weeks prior to study enrollment
- •16)Use of any drug that alters gut microbiota or function, such as laxatives, antiemetics, cisapride, antisecretory or adsorbent treatments (racecadotril, smectite, activated charcoal), opiates such as loperamide, atropine and other cholinergic agents, during 4 weeks prior to study enrollment
- •17)Intake of antifungals within 14 days prior to study enrollment
- •18)Substantial changes in eating habits within 30 days prior to receiving the first dose of IMP product, as assessed by the Investigator
- •19)Patients enrolled in another clinical trial within the past 30 days
- •20)Any condition or personal circumstance that, in the opinion of the investigator, renders the subject unlikely or unable to comply with the full study protocol.
- •21)Current smoker
- •22)Breast-feeding woman.
研究者
相似试验
招募中
3 期
Probiotic saccharomyces boulardi in knee osteoarthritisIRCT20161022030424N4Tabriz University of Medical Sciences70
招募中
不适用
The effect of yeast probiotic (saccharomyces boulardii) on acute diarrhea in childreAcute diarrhea.ShigellosisIRCT2017090812897N3Qazvin University of Medical Sciences60
招募中
1 期
The effect of probiotic Saccharomyces Bulardi in Multiple Sclerosis (MS)Multiple sclerosisIRCT20161022030424N1Tabriz University of Medical Sciences50
已完成
2 期
The effect of probiotic on uremic toxins and quality of life in chronic hemodialysis patientsIRCT20170609034406N4Tabriz University of Medical Sciences60
尚未招募
3 期
Role of Probiotics in acute diarrhea in children of age 6 months to 5 years.CTRI/2024/01/061370Kumari Akanksha Rani